Article Details
Retrieved on: 2023-10-27 13:50:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The mRNA-1083 candidate selected to advance to phase 3 achieved hemagglutination inhibition antibody titers similar to or greater than both licensed ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here